biotech firesales Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

scaram(o)uche

To: semi_infinite who wrote (3579)	11/13/2018 2:28:08 PM
From: tuck	1 Recommendation Read Replies (1) of 3661

Good call. Madrigal (MDGL) off 18% now after presenting data that seems to have met expectations. Concerns now are lack of catalysts and perhaps that manufacturing for P3 that is to start in a few months hasn't been publicly addressed. Really, the story hasn't changed much since $300. MDGL continues to have the cleanest dataset out there, IMHO, though VKTX is sort of close (in some ways apparently better, but there are caveats to comparing the data, much discussed elsewhere). Dunno where the bottom is for MDGL, but this looks a bit like capitulation to me. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next